Continuity Biosciences, LLC research brief
CIK 2029079
Generated Nov. 13, 2026, 3:50 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: BRADENTON Florida. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Aug. 19, 2025 · D · 0002029079-25-000002 · Source evidence
Reported offering amount: 12000000 USD. Reported amount sold: 8424490 USD.
- June 4, 2025 · D · 0002029079-25-000001 · Source evidence
Reported offering amount: 1000000 USD. Reported amount sold: 1000000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Continuity Biosciences, LLC research brief,” CIK 2029079, retrieved Nov. 13, 2026, 3:50 a.m.. Cite the specific accessions used. No amounts have been summed.